JP2020188926A - Skin graft prosthesis/buffer member for auricle skin defective part - Google Patents
Skin graft prosthesis/buffer member for auricle skin defective part Download PDFInfo
- Publication number
- JP2020188926A JP2020188926A JP2019095664A JP2019095664A JP2020188926A JP 2020188926 A JP2020188926 A JP 2020188926A JP 2019095664 A JP2019095664 A JP 2019095664A JP 2019095664 A JP2019095664 A JP 2019095664A JP 2020188926 A JP2020188926 A JP 2020188926A
- Authority
- JP
- Japan
- Prior art keywords
- amniotic membrane
- skin
- dried
- amnion
- pressure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002950 deficient Effects 0.000 title description 4
- 210000001691 amnion Anatomy 0.000 claims abstract description 56
- 230000007547 defect Effects 0.000 claims abstract description 21
- 238000001035 drying Methods 0.000 claims abstract description 13
- 206010033675 panniculitis Diseases 0.000 claims abstract description 9
- 210000004304 subcutaneous tissue Anatomy 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000000463 material Substances 0.000 claims description 6
- 210000000613 ear canal Anatomy 0.000 claims description 5
- 230000003139 buffering effect Effects 0.000 claims description 4
- 210000004379 membrane Anatomy 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 claims description 2
- 210000002808 connective tissue Anatomy 0.000 claims description 2
- 210000002919 epithelial cell Anatomy 0.000 claims description 2
- 210000001519 tissue Anatomy 0.000 abstract description 5
- 208000006735 Periostitis Diseases 0.000 abstract description 3
- 230000035876 healing Effects 0.000 abstract description 3
- 210000003460 periosteum Anatomy 0.000 abstract description 3
- 238000010438 heat treatment Methods 0.000 abstract description 2
- 238000011084 recovery Methods 0.000 abstract description 2
- 230000001678 irradiating effect Effects 0.000 abstract 1
- 230000006837 decompression Effects 0.000 description 11
- 206010028980 Neoplasm Diseases 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 7
- 206010052428 Wound Diseases 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 206010004146 Basal cell carcinoma Diseases 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 208000009129 Ear Neoplasms Diseases 0.000 description 4
- 208000031083 ear cancer Diseases 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000029663 wound healing Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 3
- 210000000845 cartilage Anatomy 0.000 description 2
- 210000004728 ear cartilage Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000010827 pathological analysis Methods 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000035346 Margins of Excision Diseases 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 239000006261 foam material Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 238000009581 negative-pressure wound therapy Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000003454 tympanic membrane Anatomy 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
本発明は、耳介皮膚欠損部への植皮に用いる補填・緩衝部材に関する。 The present invention relates to a filling / cushioning member used for skin grafting on a pinna skin defect.
癌などの発症により、皮膚摘出術後の欠損部に植皮を行うと部位によっては生着しづらい事が分かっている。耳介癌(基底細胞癌)では、耳介皮膚欠損部に植皮を行っても、感染を起こし易く、生着しないことが多い。 It is known that skin grafting on the defect after skin grafting makes it difficult for some parts to survive due to the onset of cancer or the like. In auricular cancer (basal cell carcinoma), even if skin grafts are performed on the auricular skin defect, infection is likely to occur and often does not engraft.
羊膜は難治性創傷に対する有用な被覆材として利用されてきた。 Amniotic membrane has been used as a useful dressing for refractory wounds.
羊膜は、コラーゲンと弾性線維で構成された強靱な生体膜であり、生羊膜は、外傷や熱傷に対する有用な被覆材料として報告されている(非特許文献1)。
しかし、必要なときにすぐに手に入らないこと、保存や取り扱いが煩雑であったことから実際の臨床では限定的な使用にとどまっていた。これに対して、特定の乾燥処理により製造される乾燥羊膜(ハイパードライヒト乾燥羊膜:以下、HD羊膜)が報告されている(特許文献1、非特許文献2)。
The amniotic membrane is a tough biological membrane composed of collagen and elastic fibers, and the raw amniotic membrane has been reported as a useful covering material for trauma and burns (Non-Patent Document 1).
However, it was only used in a limited way in actual clinical practice because it was not immediately available when needed and it was complicated to store and handle. On the other hand, dried amniotic membranes (hyper-dried human dried amniotic membranes: hereinafter, HD amniotic membranes) produced by a specific drying treatment have been reported (Patent Document 1, Non-Patent Document 2).
癌などの発症により、耳介皮膚摘出術にともない欠損部には植皮を行うが、部位によっては生着しづらい事ことがある。特に耳介癌(基底細胞癌)では、耳介皮膚欠損部に植皮を行っても、感染を起こし易く、生着しないことが多い。
軟骨膜、皮下組織欠損NPWTは、創部の上にポリウレタン等のフォーム材を置き、創部全体を覆うようにフィルム材で被覆してから、被覆された創内に持続的に陰圧をかけることで創傷治癒を促進する創管理の方法である。
今回の研究では軟骨膜、皮下組織欠損により露出軟骨上にハイパードライ羊膜を置くことで良好なスカフォールドを形成できた点が、本方法の利点である。
これまでに植皮が不良で直接的に治癒を促進する効果を持つ材料は無く、患部の壊死を避けるのみであった。
Due to the onset of cancer, skin grafting is performed on the defective part due to auricular skin removal, but it may be difficult to survive depending on the part. In particular, in auricular cancer (basal cell carcinoma), even if skin grafts are performed on the auricular skin defect, infection is likely to occur and often does not engraft.
For perichondrium and subcutaneous tissue defects NPWT, a foam material such as polyurethane is placed on the wound, covered with a film material so as to cover the entire wound, and then a continuous negative pressure is applied to the covered wound. It is a method of wound management that promotes wound healing.
In this study, the advantage of this method was that a good scaffold could be formed by placing the hyperdry amniotic membrane on the exposed cartilage due to defects in the perichondrium and subcutaneous tissue.
So far, there is no material that has a poor skin graft and has the effect of directly promoting healing, and only avoids necrosis of the affected area.
発明者らは、HD羊膜の細胞の足場(scaffold)としての機能、や組織再生の促進などが植皮生着に関与していることを明らかとし、本発明を完成するに至った。 The inventors have clarified that the function of HD amniotic membrane as a scaffold of cells and promotion of tissue regeneration are involved in skin graft engraftment, and have completed the present invention.
本発明にかかる補填・緩衝部材によれば、耳介皮膚欠損部の植皮に用いられる修復材であって、人を含む動物の胎児を包む生羊膜を乾燥処理して得た乾燥羊膜であって、前記乾燥羊膜が無菌状態の乾燥大気中で保存できるように脱水乾燥されており、かつ水又は緩衝液に浸漬して再水和した羊膜には、前記生羊膜を構成する上皮細胞、基底膜、及び結合組織が保持されている乾燥羊膜であることを特徴としている。
この構成を採用することによって、創傷治癒促進作用の能動的な作用により、植皮生着を促進する。
また、植皮生着に用いられる補填・緩衝部材であってもよい。
According to the filling / buffering member according to the present invention, it is a restoration material used for planting a skin defect in the ear canal, and is a dried amniotic membrane obtained by drying a raw amniotic membrane wrapping an animal foetation including a human. The dried amniotic membrane is dehydrated and dried so that it can be stored in a sterile dry air, and the amniotic membrane rehydrated by immersing it in water or a buffer solution includes epithelial cells and basal membranes constituting the raw amniotic membrane. , And a dry amniotic membrane that retains connective tissue.
By adopting this configuration, skin graft engraftment is promoted by the active action of the wound healing promoting action.
Further, it may be a filling / cushioning member used for skin grafting.
本発明の補填・緩衝部材を軟骨膜欠損部、皮下組織欠損部の植皮術で使用することで、羊膜の創傷治癒促進作用の能動的な作用により、植皮生着を促進することができる。 By using the filling / buffering member of the present invention in skin grafting of a perichondrium defect and a subcutaneous tissue defect, skin grafting can be promoted by the active action of the wound healing promoting action of the amniotic membrane.
(本実施形態の概要)
特定の乾燥処理(ハイパードライ)により製造される乾燥羊膜とは、例えば、特許文献1に記載された乾燥羊膜である。すなわち、処理槽内に載置した生羊膜を処理槽内に設けた赤外線ヒーターによって連続して加温して、処理槽内を減圧状態とする減圧操作と、減圧状態の処理槽内を僅かに大気圧側に上昇させる復圧操作時に、この生羊膜に処理槽内に設けたマイクロ波発生装置からもマイクロ波を照射して羊膜中に存在する水分子にエネルギーを加えつつ乾燥を行う。これを複数回繰り返すことによって製造される乾燥羊膜(HD羊膜)は、羊膜細胞自体は不活化されるが、その細胞・組織構造が保持される。
(Outline of this embodiment)
The dried amniotic membrane produced by a specific drying treatment (hyperdry) is, for example, the dried amniotic membrane described in Patent Document 1. That is, a decompression operation in which the raw amniotic membrane placed in the treatment tank is continuously heated by an infrared heater provided in the treatment tank to put the inside of the treatment tank in a decompression state, and a slight amount in the treatment tank in the decompression state. At the time of the decompression operation to raise the pressure to the atmospheric pressure side, the raw amniotic membrane is also irradiated with microwaves from the microwave generator provided in the treatment tank to dry the amniotic membrane while applying energy to the water molecules existing in the amniotic membrane. In the dried amniotic membrane (HD amniotic membrane) produced by repeating this multiple times, the amniotic membrane cells themselves are inactivated, but the cell / tissue structure is retained.
耳介癌(基底細胞癌)にて他科で摘出術を行い、耳介皮膚欠損部に植皮を行ったが、患部に癌の残存が認められ、一部感染を起こして生着しない(図1)。
前回摘出した部位からセーフティーマージンを取り、迅速病理診断で癌が残存していないことを確認した後、一塊にして摘出(図2)。露出した耳介軟骨面にHD羊膜を貼付後(図3a)、その上に採取した皮膚を植皮する(図3b)。
2ヶ月後、術後経過は良好となる(図4)。
本実施形態では、軟骨膜欠損部、皮下組織欠損部に補填・緩衝部としてHD羊膜を配置する。HD羊膜を足場として軟骨膜欠損部、皮下組織欠損部と植皮との間に配置することによって、羊膜の創傷治癒促進作用、足場形成などの能動的な作用を促す。
For auricular cancer (basal cell carcinoma), excision was performed at another department, and skin grafts were performed on the auricular skin defect, but cancer remained in the affected area, causing partial infection and not engrafting (Fig.) 1).
A safety margin was taken from the previously removed site, and after confirming that no cancer remained by rapid pathological diagnosis, the cancer was removed as a mass (Fig. 2). After applying the HD amniotic membrane to the exposed auricular cartilage surface (Fig. 3a), the collected skin is grafted on it (Fig. 3b).
After 2 months, the postoperative course is good (Fig. 4).
In the present embodiment, the HD amniotic membrane is placed as a filling / buffering portion in the perichondrium defect portion and the subcutaneous tissue defect portion. By arranging the HD amniotic membrane as a scaffold between the perichondrium defect and the subcutaneous tissue defect and the skin graft, the wound healing promoting action of the amniotic membrane and the active action such as scaffold formation are promoted.
・HD羊膜の製造
図5に示す乾燥装置を用いて下記の真空・遠赤外線・マイクロウエーブ各装置の条件において、生羊膜を乾燥した。
・乾燥槽加温:50℃、F.I.R:50℃、ストッフ゜弁:37%、最高到達圧力0.34kPa 空運転最高到達圧力0.33kPa
・乾燥処理の方法
(1)減圧 180sec
(2)復圧 30sec(ストッフ゜弁開度37%)
マイクロ波投入 0.1kw−180sec(復圧は継続)
(3)減圧 180sec
(4)以降、(2)・(3)の繰返し
(5)乾燥終了は、(3)の180sec減圧後到達圧力を確認し(0.30〜0.35 kPa)、手動にて行う。
大気圧まで復圧し終了
-Production of HD amniotic membrane The raw amniotic membrane was dried under the conditions of the following vacuum, far-infrared, and microwave devices using the drying device shown in FIG.
・ Drying tank heating: 50 ℃, FIR: 50 ℃, Stop valve: 37%, Maximum ultimate pressure 0.34kPa Empty operation Maximum ultimate pressure 0.33kPa
・ Drying method (1) Decompression 180sec
(2) Restoration pressure 30 seconds (stop valve opening 37%)
Microwave input 0.1kw-180sec (recovery continues)
(3) Decompression 180 sec
After (4), repeat (2) and (3) (5) Finish drying by checking the ultimate pressure after 180 sec decompression of (3) (0.30 to 0.35 kPa) and manually.
Restored to atmospheric pressure and finished
特定の乾燥処理により製造される乾燥羊膜(HD羊膜)、すなわち処理槽内に載置した生羊膜を処理槽内に設けた赤外線ヒーターによって連続して加温して、処理槽内を減圧状態とする減圧操作と、減圧状態の処理槽内を僅かに大気圧側に上昇させる復圧操作時に、この生羊膜に処理槽内に設けたマイクロ波発生装置からもマイクロ波を照射して羊膜中に存在する水分子にエネルギーを加えつつ乾燥を行う。これを複数回繰り返すことによって細胞・組織構造を保持しつつ乾燥させた羊膜は、保存性が向上すると共に、取り扱いがしやすい。このHD羊膜を、軟骨膜・骨膜欠損および皮下組織の欠損時に、植皮の不良を防ぐ目的で用いる足場として使用することで、植皮による治癒効果を高めることができる。 The dried amniotic membrane (HD amniotic membrane) produced by a specific drying treatment, that is, the raw amniotic membrane placed in the treatment tank, is continuously heated by an infrared heater provided in the treatment tank to reduce the pressure inside the treatment tank. During the decompression operation and the decompression operation to slightly raise the inside of the processing tank in the depressurized state to the atmospheric pressure side, the raw amniotic membrane is also irradiated with microwaves from the microwave generator provided in the treatment tank to enter the amniotic membrane. Drying is performed while applying energy to the existing water molecules. The amniotic membrane dried while retaining the cell / tissue structure by repeating this a plurality of times has improved storage stability and is easy to handle. By using this HD amniotic membrane as a scaffold used for the purpose of preventing poor skin grafting when the perichondrium / periosteum is defective and the subcutaneous tissue is defective, the healing effect of skin grafting can be enhanced.
10 処理槽
12 回転テーブル
14 遠赤外線ヒータ
16 モータ
18 真空ポンプ
20 電磁弁
22 減圧配管
24 フィルター
28 復圧配管
30 マイクロ波照射装置
10 Processing tank 12 Rotating table 14 Far-infrared heater 16 Motor 18 Vacuum pump 20 Solenoid valve 22 Decompression pipe 24 Filter 28 Decompression pipe 30 Microwave irradiation device
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019095664A JP2020188926A (en) | 2019-05-22 | 2019-05-22 | Skin graft prosthesis/buffer member for auricle skin defective part |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019095664A JP2020188926A (en) | 2019-05-22 | 2019-05-22 | Skin graft prosthesis/buffer member for auricle skin defective part |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2020188926A true JP2020188926A (en) | 2020-11-26 |
Family
ID=73453062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019095664A Pending JP2020188926A (en) | 2019-05-22 | 2019-05-22 | Skin graft prosthesis/buffer member for auricle skin defective part |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2020188926A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007054015A (en) * | 2005-08-26 | 2007-03-08 | Toyama Univ | Dry amnion and method for drying treatment of amnion |
-
2019
- 2019-05-22 JP JP2019095664A patent/JP2020188926A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007054015A (en) * | 2005-08-26 | 2007-03-08 | Toyama Univ | Dry amnion and method for drying treatment of amnion |
Non-Patent Citations (1)
Title |
---|
日本耳鼻咽喉科学会会報, vol. 121, no. 4, JPN6023000989, 2018, pages 595 - 009, ISSN: 0005103564 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11957814B2 (en) | Adipose tissue matrices | |
JP5224250B2 (en) | Medical substitute membrane | |
US8932641B2 (en) | Dried amnion and method for drying treatment of amnion | |
KR101163594B1 (en) | Method for producing tooth bone graft materials and tooth bone graft materials produced by thereof | |
AU2020267589B2 (en) | Tissue derived porous matrices and methods for making and using same | |
JP2022534110A (en) | biological breast implants | |
WO2022091321A1 (en) | Skin graft supplementing/cushioning member for auricle skin defect | |
JP2020188926A (en) | Skin graft prosthesis/buffer member for auricle skin defective part | |
WO2020008258A3 (en) | Stabilization of collagen scaffolds | |
EP3188596A1 (en) | Human dermis, preparation and use thereof | |
CN111359020B (en) | Soft tissue repair material and preparation method and application thereof | |
RU2769248C1 (en) | Method for obtaining acellular dermal matrix | |
JP2008036345A (en) | Medical material for reconstructing surface of eye made of dried amnion | |
US9023342B2 (en) | Tissue grafting method | |
KR102586304B1 (en) | Acellular nerve graft and method of making the same | |
US20100135964A1 (en) | Tissue grafting method | |
US20170080127A1 (en) | Biologically active graft for skin replacement therapy | |
CN106693079B (en) | Guided tissue regeneration membrane and preparation method thereof | |
CN115025296A (en) | Oral cavity repairing membrane for guiding tissue regeneration and preparation method and related kit thereof | |
PE5297A1 (en) | IMPLANT | |
Smith | XLVIII Care of Mastoid Wounds: Following the Radical and Modified Radical Mastoid Operations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220324 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20230110 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230117 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20230711 |